Lower inflammation is related to greater energy levels in adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
Elexacaftor/tezacaftor/ivacaftor can be effective for people with cystic fibrosis with the 3849 gene variant
Two-year follow-up results from an ongoing study on the safety and effectiveness of elexacaftor/tezacaftor/ivacaftor when used in real-world settings by people with cystic fibrosis
Testicular pain following initiation of elexacaftor/tezacaftor/ivacaftor in males with cystic fibrosis
New drug for cystic fibrosis does not significantly interfere with another drug that prevents organ rejection
Infant with cystic fibrosis has normal pancreas function and was missed by newborn screening after mom stayed on CFTR modulator therapy during pregnancy.
Testicular Pain Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Males With Cystic Fibrosis
